Valencia Nutrition (VALENCIA) | Financial Analysis & Statements
Valencia Nutrition Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2019Income Metrics
Revenue
1.3M
Gross Profit
-5.9M
-453.63%
Operating Income
-5.1M
-392.81%
Net Income
-5.1M
-393.51%
Balance Sheet Metrics
Total Assets
404.2M
Total Liabilities
18.4M
Shareholders Equity
365.8M
Debt to Equity
0.05
Cash Flow Metrics
Operating Cash Flow
-8.1M
Free Cash Flow
-18.4M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2019
Annual Income Flow
2025
Valencia Nutrition Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 84.7M | 13.4M | 14.6M | 0 | 9.5M |
| Cost of Goods Sold | 44.8M | 17.8M | 15.4M | 131.0K | 17.7M |
| Gross Profit | 39.9M | -4.4M | -771.0K | -131.0K | -8.2M |
| Gross Margin % | 47.1% | -33.2% | -5.3% | 0.0% | -85.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | 0 | 81.0K |
| Selling, General & Administrative | 4.5M | 2.4M | 1.5M | 386.0K | 1.4M |
| Other Operating Expenses | 15.4M | 3.6M | 5.7M | 3.3M | 7.6M |
| Total Operating Expenses | 19.9M | 6.0M | 7.3M | 3.6M | 9.0M |
| Operating Income | 6.5M | -16.7M | -12.6M | -6.3M | -29.9M |
| Operating Margin % | 7.6% | -124.7% | -86.4% | 0.0% | -313.4% |
| Non-Operating Items | |||||
| Interest Income | 5.4M | 12.0K | 0 | 4.0K | 230.0K |
| Interest Expense | 1.2M | 316.0K | 0 | 70.0K | 897.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 10.7M | -13.8M | -12.6M | -6.7M | -35.8M |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 10.7M | -13.8M | -12.6M | -6.7M | -35.8M |
| Net Margin % | 12.7% | -103.7% | -86.5% | 0.0% | -374.6% |
| Key Metrics | |||||
| EBITDA | 13.4M | -16.1M | -11.9M | -5.6M | -28.4M |
| EPS (Basic) | ₹0.77 | ₹-2.48 | ₹-2.26 | ₹-0.66 | ₹-3.60 |
| EPS (Diluted) | ₹0.76 | ₹-2.48 | ₹-2.26 | ₹-0.66 | ₹-3.60 |
| Basic Shares Outstanding | 16980341 | 5585341 | 5585341 | 9929495 | 9929495 |
| Diluted Shares Outstanding | 16980341 | 5585341 | 5585341 | 9929495 | 9929495 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Valencia Nutrition Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.4M | 2.2M | 755.0K | 457.0K | 2.7M |
| Short-term Investments | - | - | - | - | 161.2K |
| Accounts Receivable | 84.8M | 9.7M | 2.9M | 580.0K | 221.0K |
| Inventory | 26.6M | 7.0M | 8.4M | 782.0K | 782.0K |
| Other Current Assets | 821.0K | 398.0K | 998.0K | 109.0K | 101.0K |
| Total Current Assets | 272.9M | 33.7M | 25.5M | 21.6M | 22.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 3.3M | 26.7M | 4.5M | 4.5M | 14.1M |
| Goodwill | 1.4M | 0 | - | - | - |
| Intangible Assets | 1.4M | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | -1.0K | -1.0K | -60.0K |
| Total Non-Current Assets | 131.3M | 26.3M | 2.4M | 2.9M | 14.7M |
| Total Assets | 404.2M | 60.0M | 27.8M | 24.5M | 36.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.3M | 2.4M | 3.2M | 2.2M | 5.6M |
| Short-term Debt | 0 | 0 | 0 | 0 | 3.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 917.0K | 23.6M | 8.5M | 9.3M | 3.0M |
| Total Current Liabilities | 3.5M | 27.1M | 12.7M | 12.5M | 22.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 14.9M | 53.4M | 21.8M | 6.0M | 1.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 1.0K | - | - | 1.0K | 1.0K |
| Total Non-Current Liabilities | 14.9M | 53.4M | 21.8M | 6.0M | 1.8M |
| Total Liabilities | 18.4M | 80.5M | 34.5M | 18.5M | 24.3M |
| Equity | |||||
| Common Stock | 169.8M | 55.9M | 55.9M | 55.9M | 55.9M |
| Retained Earnings | -179.8M | -190.6M | -176.7M | -164.1M | -157.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 365.8M | -20.5M | -6.7M | 6.0M | 12.6M |
| Key Metrics | |||||
| Total Debt | 14.9M | 53.4M | 21.8M | 6.0M | 5.6M |
| Working Capital | 269.4M | 6.6M | 12.8M | 9.1M | -287.0K |
Balance Sheet Composition
Valencia Nutrition Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 10.7M | -13.8M | -12.6M | -6.6M | -35.8M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -165.1M | 6.1M | -4.6M | -4.5M | -2.0M |
| Operating Cash Flow | -158.5M | -7.4M | -17.3M | -11.0M | -37.1M |
| Investing Activities | |||||
| Capital Expenditures | -40.8M | -22.2M | 0 | 11.2M | -1.2M |
| Acquisitions | -29.3M | 0 | - | - | - |
| Investment Purchases | - | 0 | 0 | 0 | 0 |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -70.1M | -22.2M | 0 | 11.2M | -1.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 31.6M | 15.8M | 4.2M | 0 |
| Debt Repayment | -38.5M | 0 | 0 | 0 | -821.0K |
| Financing Cash Flow | 337.1M | 31.6M | 15.8M | 4.2M | -821.0K |
| Free Cash Flow | -198.1M | -29.8M | -15.5M | -13.5M | -26.1M |
| Net Change in Cash | 108.5M | 1.9M | -1.4M | 4.4M | -39.1M |
Cash Flow Trend
Valencia Nutrition Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
38.74
Price to Book
3.56
Price to Sales
12.67
Profitability Ratios
Profit Margin
27.73%
Operating Margin
19.80%
Return on Equity
10.80%
Return on Assets
4.41%
Financial Health
Current Ratio
33.13
Debt to Equity
47.66
Beta
0.51
Per Share Data
EPS (TTM)
₹2.02
Book Value per Share
₹21.98
Revenue per Share
₹5.77
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| VALENCIA | 1.1B | 38.74 | 3.56 | 10.80% | 27.73% | 47.66 |
| Biocon | 566.5B | 71.84 | 1.68 | 3.66% | 3.59% | 50.02 |
| OneSource Specialty | 202.8B | 936.63 | 3.11 | -0.31% | 1.42% | 21.93 |
| Zota Health Care | 39.4B | -62.53 | 12.61 | -24.83% | -15.37% | 56.90 |
| Dishman Carbogen | 26.5B | 22.30 | 0.42 | 0.06% | 4.25% | 40.20 |
| Panacea Biotec | 21.8B | 182.62 | 2.65 | -1.01% | -1.29% | 2.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.





